These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6808793)

  • 1. [Serological heterogeneity of the immune response to the administration of a multicomponent meningococcal vaccine].
    Belova TN; Efimov DD
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):94-8. PubMed ID: 6808793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bactericidal antibodies to meningococcal serogroups A, B and C in persons inoculated with a polycomponent meningococcal vaccine].
    Belova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):95-7. PubMed ID: 6805176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic relations of meningococcal serogroups Z and 29E].
    Zhukova LF; Ereshchenko VV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):65-8. PubMed ID: 6817563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Level of IgG antibodies to bacteria of 12 species in the blood sera of rabbits, immunized with preparations obtained from Neisseria meningitidis, grown under the stress conditions].
    Basnak'ian IA; Aleksakhina NN; Iastrebova NE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):14-9. PubMed ID: 16279527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antibody response of animals to a corpuscular meningococcal group-B preparation with different methods of immunization].
    Aleksakhina NN; Basnak'ian IA; Kolenko VM; Borovkova VM; Saraeva LV; Stukalova NV; Karabak VI
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (7-8):30-4. PubMed ID: 1466168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
    Tappero JW; Lagos R; Ballesteros AM; Plikaytis B; Williams D; Dykes J; Gheesling LL; Carlone GM; Høiby EA; Holst J; Nøkleby H; Rosenqvist E; Sierra G; Campa C; Sotolongo F; Vega J; Garcia J; Herrera P; Poolman JT; Perkins BA
    JAMA; 1999 Apr; 281(16):1520-7. PubMed ID: 10227322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
    Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Makeup and properties of a polycomponent meningococcal vaccine].
    Efimov DD; Belova TN; Zvenigorodskaia VP; Krasnoproshina LI; Klimenkova VF
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):63-7. PubMed ID: 85399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential.
    Gorringe AR; Borrow R; Fox AJ; Robinson A
    Vaccine; 1995 Sep; 13(13):1207-12. PubMed ID: 8578805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
    Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
    Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.